October 26, 2026

Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development

Lunit and Summit Therapeutics: Research Will Use Lunit’s AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment Biology  Seoul, South Korea and Miami, Florida, October 23, 2026 – Lunit Inc....

recent articles

I never met my paternal grandfather. He passed away from a massive stroke about a year before I was born. I was named after him but know very little of his early life. He came from Russia when he was 3 years old and the family settled in...

Exciting news today from FDA with news of approval of first liquid biopsy test for use in non-small cell lung cancer.  The cobas EGFR test is already approved for use in formalin-fixed paraffin-embedded (FFPE) tissue. This new use is intended...

OracleBio, a leading provider of high quality precision histopathology image analysis services to support Pharmaceutical R&D, companion diagnostics development, pathology review and biomarker research, will be exhibiting at the American...

Curious to see how 30,000 practicing oncologists react to this and what the level of interest will be in what the VP has to say.  My general sense over these past few months among oncologists is a fair amount of skepticism to the initiative...

microDimensions has launched an upgraded version of its free digital pathology viewer Zoom, including a set of features to facilitate collaboration of researchers working on digital whole slide images. The version 2.0 enables loading and...

OR

platinum partners

gold partners

Silver Partners

Media Partners